Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) FCF Margin: 2012-2022

Historic FCF Margin for RedHill Biopharma (RDHL) over the last 11 years, with Dec 2022 value amounting to -18.92%.

  • RedHill Biopharma's FCF Margin rose 4841.00% to -18.92% in Q4 2022 from the same period last year, while for Dec 2022 it was -47.22%, marking a year-over-year increase of 2863.00%. This contributed to the annual value of -116.60% for FY2024, which is 43212.00% up from last year.
  • RedHill Biopharma's FCF Margin amounted to -18.92% in Q4 2022, which was up 44.92% from -34.34% recorded in Q3 2022.
  • RedHill Biopharma's 5-year FCF Margin high stood at -18.92% for Q4 2022, and its period low was -1,006.06% during Q1 2020.
  • Over the past 3 years, RedHill Biopharma's median FCF Margin value was -63.47% (recorded in 2021), while the average stood at -135.80%.
  • Per our database at Business Quant, RedHill Biopharma's FCF Margin plummeted by 13,932,883bps in 2018 and then skyrocketed by 94,644bps in 2021.
  • RedHill Biopharma's FCF Margin (Quarterly) stood at -602.94% in 2018, then slumped by 26,932bps to -872.26% in 2019, then skyrocketed by 84,265bps to -29.62% in 2020, then tumbled by 3,771bps to -67.32% in 2021, then skyrocketed by 4,841bps to -18.92% in 2022.
  • Its FCF Margin was -18.92% in Q4 2022, compared to -34.34% in Q3 2022 and -90.38% in Q2 2022.